Key Sessions
Sarah Snykers
Transforming Cell Therapy Manufacturing: Legend's Journey from Start Up to Commercial Manufacturing and Beyond
Legend Biotech
Rutger Douma
Establishing a Network to Produce Lentiviral Vectors for Carvykti®
Johnson & Johnson Innovative Medicine
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Wednesday 4th November – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Wednesday 4th November – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
search
Streams
Clear
Showing 1 of 1 Streams
Cell Therapy Manufacturing & Analytics
11:10 - 11:15
Chairperson’s Opening Remarks: Cell Therapy Manufacturing & Analytics
11:15 - 11:45
Transforming Cell Therapy Manufacturing: Legend's Journey from Start Up to Commercial Manufacturing and Beyond
- Sarah Snykers - Head of Site Strategy & Excellence, Legend Biotech
11:45 - 12:15
Commercialisation of Cell Therapies: Cell Therapy Manufacturing Scale Up from Clinical to Commercial
- Ketki Flannery - Associate Director MSAT and CMC, Autolous Therapeutics
Showing 1 of 1 Streams
Cell Therapy Manufacturing & Analytics
14:00 - 14:30
Balancing Personalisation & Scalability in TCR-T Cell Therapies to Scale the Modality
- Anette Brass - Head of Process Development, Anocca AB
14:30 - 15:00
Quality by Design in Cell Therapy Manufacturing – Implementation of Process Improvements
- Volker Huppert - Chief Development Officer, Glycostem Therapeutics
15:00 - 15:30
Sponsored Scientific Track Presentation
Showing 1 of 1 Streams
Cell Therapy Manufacturing & Analytics
16:20 - 16:50
Cell Therapy Reimagined: The Science of Continuous Improvement in Quality and Performance
- Ramiz Saramati - QA Operations Expert, Novartis
16:50 - 17:20
End to End Workflow Automation in Cell Therapy Manufacturing: Strategies for Implementation at Scale
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
